Neumora Therapeutics, Inc. (NMRA)
0.487
-0.08
(-13.96%)
USD |
NASDAQ |
Nov 05, 16:00
0.473
-0.01
(-2.87%)
After-Hours: 20:00
Neumora Therapeutics Net Income (TTM) : -212.74M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -212.74M |
| March 31, 2026 | -222.39M |
| December 31, 2025 | -236.93M |
| September 30, 2025 | -236.30M |
| June 30, 2025 | -252.09M |
| March 31, 2025 | -258.06M |
| December 31, 2024 | -243.79M |
| September 30, 2024 | -293.70M |
| Date | Value |
|---|---|
| June 30, 2024 | -274.18M |
| March 31, 2024 | -254.02M |
| December 31, 2023 | -235.92M |
| September 30, 2023 | -155.34M |
| June 30, 2023 | -131.66M |
| March 31, 2023 | -123.49M |
| December 31, 2022 | -130.90M |
| September 30, 2022 | -118.06M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| EyePoint, Inc. | -306.64M |
| Context Therapeutics, Inc. | -45.96M |
| LENZ Therapeutics, Inc. | -140.27M |
| BioAge Labs, Inc. | -94.46M |
| ANI Pharmaceuticals, Inc. | 99.95M |